Abstract:Background: The role of senescent cells in the tumor microenvironment (TME) is usually bilateral, and diverse therapeutic approaches, such as radiotherapy and chemotherapy, can induce cellular senescence. Cellular interactions are widespread in the TME, and tumor cells reprogram immune cells metabolically by producing metabolites. However, how senescent cells remodel the metabolism of TME remains unclear. This study aimed to explore precise targets to enhance senescent cells-induced anti-tumor immunity from a metabolic perspective. Methods: The in vivo senescence model was induced by 8 Gy×3 radiotherapy or cisplatin chemotherapy, and the in vitro model was induced by 10 Gy-irradiation or cisplatin treatment. Metabonomic analysis and ELISA assay on tumor interstitial fluid were performed for metabolites screening. Marker expression and immune cell infiltration in the TME were analyzed by flow cytometry. Cell co-culture system and senescence-conditioned medium were used for crosstalk validation in vitro. RNA sequencing and rescue experiments were conducted for mechanism excavation. Immunofluorescence staining and single-cell transcriptome profiling analysis were performed for clinical validation. Results: We innovatively reveal the metabolic landscape of the senescent TME, characterized with the elevation of adenosine. It is attributed to the senescent tumor cell-induced CD73 upregulation of tumor-associated macrophages (TAMs). CD73 expression in TAMs is evoked by SASP-related pro-inflammatory cytokines, especially IL-6, and regulated by JAK/STAT3 pathway. Consistently, a positive correlation between tumor cells senescence and TAMs CD73 expression is identified in lung cancer clinical specimens and databases. Lastly, blocking CD73 in a senescent background suppresses tumors and activates CD8+ T cell-mediated antitumor immunity. Conclusions: TAMs expressed CD73 contributes significantly to the adenosine accumulation in the senescent TME, suggesting targeting CD73 is a novel synergistic anti-tumor strategy in the aging microenvironment.

Down-regulation of Cancer-Associated Gene CDC73 Contributes to Cellular Senescence

Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression

Lung Cancer Cells Expressing a Shortened CDK16 3′UTR Escape Senescence Through Impaired Mir‐485‐5p Targeting

HNRNPA1-mediated 3′ UTR Length Changes of HN1 Contributes to Cancer- and Senescence-Associated Phenotypes

Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence.

Suppression of TCAB1 expression induced cellular senescence by lessening proteasomal degradation of p21 in cancer cells

Downregulation of Histone H3.3 Induces p53-Dependent Cellular Senescence in Human Diploid Fibroblasts

Senescence regulation by the p53 protein family.

Down-Regulation of P21(Waf1) Promotes Apoptosis in Senescent Human Fibroblasts: Involvement of Retinoblastoma Protein Phosphorylation and Delay of Cellular Aging

Global lengthening of 3ʹ untranslated regions of mRNAs by alternative cleavage and polyadenylation in cellular senescence

3′ UTR lengthening as a novel mechanism in regulating cellular senescence

Cellular senescence is regulated by p21Waf1/Cip1 methylation

Chromatin Remodeling Factor BAZ1A Regulates Cellular Senescence in Both Cancer and Normal Cells.

Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment

METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability

Enhancer of Zeste Homolog 2 Depletion Induces Cellular Senescence Via Histone Demethylation along the Ink4/Arf Locus

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

Cellular senescence in cancer: molecular mechanisms and therapeutic targets

p53/MDM2 signaling pathway in aging, senescence and tumorigenesis

Inhibiting Enhancer of Zeste Homolog 2 Promotes Cellular Senescence in Gastric Cancer Cells SGC-7901 by Activation of P21 and P16

P21waf1/cip1 Plays a Critical Role in Modulating Senescence Through Changes of DNA Methylation